Street name

A street name is an informal label that a substance acquires as it moves through unregulated markets — coined through use and trade rather than assigned by any pharmacological or regulatory body. The same compound may carry dozens of names across regions; the same name may refer to entirely different compounds depending on geography or era.

Street names exist because unregulated supply chains carry no binding nomenclature. Sellers assign names to increase recognisability or appeal; buyers adopt them for convenience. The result is a vocabulary that tracks what something is being sold as, not what it chemically is.

How it is done

Street names circulate through word of mouth, online forums, and regional market conventions. A name attaches to a product — or a loose category of products — and persists even as the underlying chemistry changes.

When a name is given to a substance class rather than a single compound, sellers may fill it with whatever is cheapest or most available at a given moment. Tablets sold under the name "Ecstasy" have contained methamphetamine, cathinones, novel psychoactive substances, and sometimes no active compound at all. "Spice" began as a label for a handful of synthetic cannabinoids and expanded to cover hundreds of structurally distinct compounds.

Someone encountering a street name — on a drug checking report, a forum, or a substance page — is reading what the substance is claimed to be, not a verified identification.

What it cannot tell you

A street name establishes nothing about the chemical identity of what it labels. It does not indicate which specific compound is present, at what concentration, or whether additional substances are mixed in. Because it carries no chemical definition, it cannot be used to look up accurate dose thresholds, interaction risks, or pharmacology with any confidence.

The central failure mode is precision illusion: a familiar name implies familiarity with the substance, but the name is a social construct, not a chemical fact. Prior experience with a substance sold under a given name offers no reliable pharmacological basis for assuming that what is sold under that same name on a different occasion, from a different source, is the same compound.

This gap is sharpest where names migrate to chemically distinct substances. Fentanyl and its analogues have entered opioid supply chains under established street names without that substitution being disclosed or apparent to buyers. Novel synthetic cannabinoids with very different potency profiles circulate under names like "Spice" or "K2" that users may associate with earlier, less potent formulations. In both cases, prior experience with the name carries no reliable guidance on what to expect.

Reagent tests and drug-checking services are the tools designed to address this gap — they attempt to identify what is actually present, not merely what it is called. They also have their own limits, which are covered in those entries.